Cartesian Therapeutics, Inc. Quarterly Depreciation in USD from Q2 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cartesian Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q2 2015 to Q3 2024.
  • Cartesian Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $300K, a 200% increase year-over-year.
  • Cartesian Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $900K, a 28.6% increase year-over-year.
  • Cartesian Therapeutics, Inc. annual Depreciation for 2023 was $700K, unchanged from 2022.
  • Cartesian Therapeutics, Inc. annual Depreciation for 2022 was $700K, a 16.7% increase from 2021.
  • Cartesian Therapeutics, Inc. annual Depreciation for 2021 was $600K, unchanged from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $900K $300K +$200K +200% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $700K $200K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $700K $200K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $700K $200K $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $700K $100K -$100K -50% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $800K $200K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $800K $200K +$100K +100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $700K $200K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $700K $200K +$100K +100% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $600K $200K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-17
Q1 2022 $600K $100K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $600K $200K +$100K +100% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 $500K $100K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $500K $200K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $500K $100K -$100K -50% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $600K $100K -$19K -16% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-02
Q3 2020 $619K $100K -$100K -50% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $719K $200K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $719K $200K +$19K +10.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $700K $119K -$112K -48.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 $812K $200K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $812K $200K -$200K -50% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.01M $181K +$12K +7.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1M $231K +$81K +54% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $919K $200K $0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $919K $400K +$200K +100% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $719K $169K -$31K -15.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $750K $150K -$174K -53.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $924K $200K +$100K +100% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $824K $200K $0 0% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $824K $200K +$22K +12.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-08-08
Q4 2016 $802K $324K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $100K -$100K -50% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $200K -$300K -60% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $178K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q3 2015 $200K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $500K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.